Cite
HARVARD Citation
Ylisaukko-oja, T. et al. (n.d.). P629 Real-life treatment persistence and treatment outcomes of Finnish patients with Inflammatory Bowel Disease receiving vedolizumab as first-line biological treatment. Journal of Crohn's and colitis. pp. i758-i759. [Online].